Literature DB >> 11120517

Placental expression of syndecan 1 is diminished in preeclampsia.

V I Jokimaa1, H P Kujari, E M Ekholm, P L Inki, L Anttila.   

Abstract

OBJECTIVE: Syndecan 1 is a cell surface heparan sulfate proteoglycan that binds growth factors and antithrombin III. The objective of this study was to examine whether placental expression of syndecan 1 in preeclampsia differs from that in normal pregnancy and whether gestational age and fetal growth affect syndecan 1 expression. STUDY
DESIGN: An immunohistochemical analysis of 30 placentas of women with severe preeclampsia and 15 placentas of women without preeclampsia was performed with the monoclonal anti-syndecan 1 antibody B-B4.
RESULTS: In 47% of preeclamptic placentas the immunoreactivity with antibody B-B4 was faint or absent, whereas 93% of the normal placentas exhibited strong immunoreactivity. The reduction in placental expression of syndecan 1 in preeclampsia was not associated with gestational age or impaired fetal growth.
CONCLUSION: The expression of syndecan 1 on the chorionic villi is reduced in preeclampsia irrespective of gestational age or fetal growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120517     DOI: 10.1067/mob.2000.107320

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Role of placenta in preeclampsia.

Authors:  Leslie Myatt
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Yi Xu; Roberto Romero; Tibor Fule; Katalin Karaszi; Gaurav Bhatti; Tibor Varkonyi; Ildiko Varkonyi; Tibor Krenacs; Zhong Dong; Adi L Tarca; Tinnakorn Chaiworapongsa; Sonia S Hassan; Zoltan Papp; Ilona Kovalszky; Nandor Gabor Than
Journal:  Virchows Arch       Date:  2013-06-27       Impact factor: 4.064

3.  Pregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through interaction with cell surface proteoglycans.

Authors:  Felipe A Lisboa; James Warren; Gisela Sulkowski; Marta Aparicio; Guido David; Enrique Zudaire; Gabriela S Dveksler
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

Review 4.  A Systematic Review of Maternal Serum Syndecan-1 and Preeclampsia.

Authors:  Kitty George; Prakar Poudel; Roopa Chalasani; Mastiyage R Goonathilake; Sara Waqar; Sheeba George; Wilford Jean-Baptiste; Amina Yusuf Ali; Bithaiah Inyang; Feeba Sam Koshy; Lubna Mohammed
Journal:  Cureus       Date:  2022-06-09

Review 5.  Proteoglycans: Systems-Level Insight into Their Expression in Healthy and Diseased Placentas.

Authors:  Orsolya Oravecz; Andrea Balogh; Roberto Romero; Yi Xu; Kata Juhasz; Zsolt Gelencser; Zhonghui Xu; Gaurav Bhatti; Roger Pique-Regi; Balint Peterfia; Petronella Hupuczi; Ilona Kovalszky; Padma Murthi; Adi L Tarca; Zoltan Papp; Janos Matko; Nandor Gabor Than
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

6.  Alpha or beta human chorionic gonadotropin knockdown decrease BeWo cell fusion by down-regulating PKA and CREB activation.

Authors:  Sudha Saryu Malhotra; Pankaj Suman; Satish Kumar Gupta
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

7.  The prediction of early preeclampsia: Results from a longitudinal proteomics study.

Authors:  Adi L Tarca; Roberto Romero; Neta Benshalom-Tirosh; Nandor Gabor Than; Dereje W Gudicha; Bogdan Done; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Panaitescu; Dan Tirosh; Nardhy Gomez-Lopez; Sorin Draghici; Sonia S Hassan; Offer Erez
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

8.  Low Soluble Syndecan-1 Precedes Preeclampsia.

Authors:  Robin E Gandley; Andrew Althouse; Arundhathi Jeyabalan; Julia M Bregand-White; Stacy McGonigal; Ashley C Myerski; Marcia Gallaher; Robert W Powers; Carl A Hubel
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.